Autosomal Dominant von Willebrand Disease Type 2M

被引:8
|
作者
Hermans, Cedric [1 ]
Batlle, Javier [2 ,3 ]
机构
[1] St Luc Univ Hosp, Hemophilia Clin, Hemostasis & Thrombosis Unit, Ctr Thrombosis & Hemostasis, BE-1200 Brussels, Belgium
[2] Univ Santiago Compostela, Dept Med, Santiago De Compostela, Spain
[3] Complexo Hosp Univ Juan Canalejo, Serv Hematol & Hemoterapia, La Coruna, Spain
关键词
Desmopressin response; Multimeric patterns; Phenotype; Platelet adhesion; Type; 2M; von Willebrand disease; COLLAGEN-BINDING ASSAY; FACTOR VWF; REVISED CLASSIFICATION; GENOTYPE; IDENTIFICATION; PHENOTYPE; VARIANT; 2A;
D O I
10.1159/000214854
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
von Willebrand disease (VWD) type 2M is a distinct entity and clearly differs from type 1. The genotype-phenotype correlation for cases with ristocetin cofactor activity (RCo)/antigen (Ag) ratios <0.60 is clear, whereas the von Willebrand factor (VWF): collagen binding (CB)/VWF: Ag ratio is normal in VWD 2M. Typical laboratory features of VWD type 2 M are decreased ristocetin-induced platelet aggregation in the presence of a normal or near normal VWF multimeric pattern on a low-resolution agarose gel, a poor response to desmopressin (DDAVP) of VWF: RCo, and a good response of both VWF: CB and VWF: Ag to DDAVP. The phenotypic definition of VWD type 2M may need to be more stringent and should be the subject of an international standardization initiative. Copyright (C) 2009 S. Karger AG, Basel
引用
收藏
页码:139 / 144
页数:6
相关论文
共 50 条
  • [1] Time for a redefinition of type 2M von Willebrand disease
    Keeling, D
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2002, 118 (03) : 922 - 922
  • [2] Type 2M Von Willebrand Disease: A Case Report
    Ghosh, Sudeshna
    Bendi, Venkata Sunil
    Krishnamurthy, Jairam
    Tandra, PavanKumar
    Kommalapati, Anuhya
    [J]. CUREUS, 2018, 10 (08):
  • [3] Type 2M von Willebrand disease:: a variant of type 2A?
    Batlle, J.
    Perez-Rodriguez, A.
    Franqueira, M. D.
    Lopez-Fernandez, M. F.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (02) : 388 - 390
  • [4] von Willebrand factor pseuclogene conversion as the cause of type 2M and type 3 von Willebrand disease
    Enayat, M. S.
    Guilliatt, A. M.
    Chalmers, E. A.
    Wilde, J. T.
    Williams, M. D.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 : 77 - 77
  • [5] New families with von Willebrand disease type 2M (Vicenza)
    Zieger, B
    Budde, U
    Jessat, U
    Zimmermann, R
    Simon, M
    Katzel, R
    Sutor, AH
    [J]. THROMBOSIS RESEARCH, 1997, 87 (01) : 57 - 64
  • [6] DDAVP treatment in a child with von Willebrand disease type 2M
    Mauz-Körholz, C
    Budde, U
    Körholz, D
    Göbel, U
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 1999, 158 (Suppl 3) : S174 - S176
  • [7] DDAVP treatment in a child with von Willebrand disease type 2M
    C. Mauz-Körholz
    U. Budde
    D. Körholz
    U. Göbel
    [J]. European Journal of Pediatrics, 1999, 158 : S174 - S176
  • [8] Type 2M von Willebrand disease variant characterized by abnormal von Willebrand factor multimerization
    Casonato, A
    Pontara, E
    Sartorello, F
    Bertomoro, A
    Durante, C
    Girolami, A
    [J]. JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2001, 137 (01): : 70 - 76
  • [9] Type 2M and Type 2A von Willebrand Disease: Similar but Different
    Favaloro, Emmanuel J.
    Pasalic, Leonardo
    Curnow, Jennifer
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2016, 42 (05): : 483 - 497
  • [10] Type 2M/2A von Willebrand disease: a shared phenotype between type 2M and 2A
    Seidizadeh, Omid
    Mollica, Luca
    Zambarbieri, Serena
    Baronciani, Luciano
    Cairo, Andrea
    Colpani, Paola
    Cozzi, Giovanna
    Pagliari, Maria Teresa
    Ciavarella, Alessandro
    Siboni, Simona M.
    Peyvandi, Flora
    [J]. BLOOD ADVANCES, 2024, 8 (07) : 1725 - 1736